Comparación de lipoproteínas de baja densidad obtenidas por fórmula de Friedewald y nuevas fórmulas en una población heterogénea by Guevara Amador, César Augusto et al.
328
Colombia Médica                  Vol. 41 Nº 4, 2010 (Octubre-Diciembre)
Comparison of low-density lipoprotein obtained from the Friedewald formula
and new formulae in a heterogeneous population
CÉSAR AUGUSTO GUEVARA-CUÉLLAR, MD1, CLAUDIA PATRICIA CRIOLLO-DÍAZ, MD2,
CARLOS ANDRÉS PINEDA-CAÑAR, MD3
SUMMARY
Introduction: Although the levels of low-density lipoprotein (LDL-C) should ideally be determined by beta quantification
or enzymatic methods, there are limitations in developing countries. The goal of this study is to compare LDL-C obtained
through three formulae (LDL-Cnf) with LDL-C obtained through the Friedewald formula (LDL-Cf) using LDL-C through
enzymatic methods as the most-accepted reference method in clinical practice (LDL-Cr).
Methods: A concordance study was carried out in a reference laboratory in Cali, Colombia. The three formulae were (mg/
dl): Men with triglycerides under 400 mg/dl: LDL-C = Total Cholesterol (TC) - triglycerides (TG) /6.5) - 45; men with
triglycerides equal to or greater than 400 mg/dl: LDL-C = (TC - (TG / 7)) -50 and women: LDL-C = (TC-(TG /6.5)) - 70.
Results: Three-hundred fifteen values were obtained of which 53% were for women. The mean age and LDL-Cr were 54
years (±15.8) and 112.1 mg/dl (±32.5), respectively. The median (interquartile range, mg/dl) of TC, high-density lipoprotein
(HDL-C) and TG were 204 mg/dl (171-229), 51 mg/dl (41-61), and 156 mg/dl (99-237), respectively. There were no
differences between mean values of LDL-Cr and LDL-Cnf (113.48 vs. 112.67 mg/dl; p=0.45). The intraclass correlation
coefficient among LDL-Cr and LDL-Cf and LDL-Cnf were high (R=0.93 and 0.92, respectively). The correlation between
LDL-Cf and LDL-Cnf was 0.95. There is no difference between the areas under the  receiver operating characteristic (ROC)
curve with the level of LDL-Cr at 160 mg/dl for LDL-Cnf and LDL-Cf. (0.94 vs. 0.93; p=0.27).
Conclusion: There is high concordance between LDL-Cf and LDL-Cnf. These formulae could be an alternative when
there are limitations to determine LDL-C because of the lack of enzymatic methods or through Friedewald formula due to
the absence of HDL-C.
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Comparación de lipoproteínas de baja densidad obtenidas por fórmula de Friedewald y nuevas fórmulas en una
población heterogénea
RESUMEN
Introducción: Aunque los niveles de colesterol de lipoproteínas de baja densidad (LDL-C) deben ser determinados
idealmente por betacuantificación o métodos enzimáticos, hay limitaciones en países en vía de desarrollo. El objetivo de este
estudio es comparar LDL-C obtenido a través de tres fórmulas (LDL-Cnf) con LDL-C obtenido a través de la fórmula de
Friedewald (LDL-Cf) usando LDL-C (LDL-Cr) enzimático considerado como referente más aceptado clínicamente.
Métodos: Se realizó un estudio de pruebas diagnósticas en un laboratorio de referencia en Cali, Colombia. Las tres
fórmulas fueron (mg/dl): Hombres con triglicéridos menores de 400 mg/dl: LDL-C= Colesterol total (CT) - triglicéridos (TG)/
6.5)- 45; hombres con triglicéridos iguales a o mayores de 400 mg/dl: LDL-C= (CT- (TG/7))- 50 y mujeres: LDL-C= (CT-
(TG/6.5))- 70.
Resultados: Se obtuvieron 315 valores de los cuales 53% eran mujeres. El promedio de edad y LDL-Cr fueron 54 años
(±15.8) y 112.1 mg/dl (±32.5), respectivamente. La mediana (rango intercuartil) de CT, lipoproteínas de alta densidad (HDL-
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C) y TG fueron de 204 mg/dl (171-229), 51 mg/dl (41-61) y
156 mg/dl (99-237), respectivamente. No hubo diferencia en
los valores promedio de LDL-Cr y LDL-Cnf (113.48 vs.
112.67 mg/dl; p=0.45). Los coeficientes de correlación
intraclase entre LDL-Cr y LDL-Cf y LDL-Cnf fueron altos
(r=0.93 y 0.92, respectivamente). La correlación entre LDL-
Cf y LDL-Cnf fue de 0.95. No hubo diferencias en las áreas
bajo la curvas de características operativas del receptor
(COR) con niveles de LDL-Cr de 160 mg/dl (0.94 vs. 093;
p=0.27).
Conclusión: Existe una alta correlación entre LDL-Cf y
LDL-Cnf. Estas formulas podrían ser una alternativa cuando
existen limitaciones para determinar el LDL-C.
Colomb Med. 2010; 41: 328-35
Palabras clave: Colesterol; LDL-C; LDL-directo;
Fórmula de Friedewald.
High levels of low-density lipoprotein cholesterol
(LDL-C) are considered as important risk factor for
cardiovascular disease and constitutes the main
therapeutic target for dyslipidemia treatment. For this
reason, the Adult Treatment Panel III (ATP III)
recommends that the standard lipid profile should be
measured in all patients 20 years of age or more every
five years and stratifies the following ranges of this
lipoprotein to evaluate cardiovascular risk: optimal:
below 100 mg/dl; near optimal/above optimal: 100-129
mg/dl; borderline-high: 130-159 mg/dl; high: 160-189
mg/dl, and very high: >190 mg/dl1.
This lipoprotein can be determined through different
methods. The Working Group on Lipoprotein
Measurement (WGLM) recommended the beta
quantification as the gold standard in its guide published
in 1995; however, the Group has recognized that this
method is expensive, unpractical, and delayed for clinical
purposes. Alternative methods, such as colorimetric
enzymatic methods, have been accepted as more
practical than beta quantification. But accessibility to
these methods is still limited. Hence, this group
recommends the determination of LDL-C by means of
the Friedewald formula (LDL-Cf) in many clinical
scenarios; while new, practical, and accurate techniques
are being developed2. The National Cholesterol
Education Program (NCEP) has established that the
new techniques should have a total analytical error
<12%, imprecision <4% and inaccuracy <4% compared
with beta quantification.
The Friedewald formula has been widely used in
many epidemiological studies that have established the
close relation between LDL-C elevated levels and
cardiovascular risk. It is currently the main method in
determining these levels in clinical scenarios. This
formula can not to be used in the presence of chylomicron
triglyceride concentration exceeding 400 mg/dl or type
III hyperlipidemia; several studies have shown its
inaccuracy in patients with diabetes3, hepatopathies,
and nepropathies4. Although this formula has several
limitations, the NCEP recommends it because of its low
costs, accessibility, and ease of use1.
Difficulties in accessing health care have been
considered factors that could increase the risk of poor
cardiovascular outcomes. This could be because preca-
rious care hinders a real estimation of cardiovascular
risk, especially in people from low socioeconomic
levels in developed countries, but factors such as race,
nutrition, and age play significant roles5-7.
This phenomenon could be more accentuated with
individuals without healthcare insurance coverage in
developing countries, where a significant proportion of
the population has no access to health care services.
However, no studies have established this association
in these countries. Within this limited scenario, a strategy
could be useful to determine LDL-C values based only
on cholesterol and triglycerides. Therefore, it is
imperative to develop alternative ways of determining
LDL-C in people with barriers to health care services.
The goal of this study is to correlate LDL-C values
obtained by enzymatic methods (LDL-Cr) to LDL-C
values obtained by means of new formulae (LDL-Cnf),
based on levels of total cholesterol and triglycerides.
METHODS
The new formulae were obtained by means of a data
mining procedure using total cholesterol (TC) values,
high-density lipoprotein cholesterol (HDL-C),
triglycerides (TG), and low-density lipoprotein (LDL-
C) obtained via the Friedewald formula. Several options
of formulae that only included TC and TG were obtained
and evaluated for the Pearson correlation with LDL-Cf
using Excel 2007 (Microsoft®). Those formulae with
moderate or high Pearson correlation were accepted (r
>0.80) for proof. Additionally, correction factors were
applied to minimize differences between LDL-Cf and
LDL-Cnf. Thus, three different formulae were obtained:
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. Men with triglycerides under 400 mg/dl
. LDL-C (mg/dl) = (TC (mg/dl) - TG (mg/dl) /6.5) -45
. Men with triglycerides equal to or greater than 400
mg/dl
. LDL-C (mg/dl) = (TC (mg/dl) - TG (mg/dl) / 7) -50
. Women
. LDL-C (mg/dl) = (TC (mg/dl) - TG (mg/dl)/6,5) - 70
Subsequently, these formulae were evaluated with
LDL-Cr values in a reference laboratory in Cali, Co-
lombia. We took some registers from January 2008 to
March 2009 that only included sex, age, and CT, HDL-
C, TG, and LDL-Cr levels. Registers not including any
of these variables were excluded. The levels of LDL-Cr
were determined by using direct enzymatic methods. In
this laboratory, blood samples are obtained in the
morning after 12 hours of fasting, according to the
protocol Manual of Laboratory Operations and
Standardization program for Lipid Measurement.
This study was approved by the Institutional Review
Board at Universidad del Valle in Cali, Colombia.
The statistical analysis was carried out by using
STATA v.10. The univariate analysis included
proportion for categorical variables, means with stan-
dard deviation, and median with interquartile range for
numeric variables according to distribution and
statistical requirements. Global and stratified Pearson
coefficients for women and men with TG greater to or
equal to 400 mg/dl and men with TG under 400 mg/dl
were obtained to estimate correlation among LDL-Cr,
LDL-Cf, and LDL-Cnf. The intraclass correlation
coefficient between LDL-Cr and LDL-Cnf was
determined with a confidence interval of 95%. After
verification of statistical assumptions and in accordance
with the distribution, the paired t test was carried out to
compare the values of LDL-C as determined by the
different formulae. The comparison of medians was
carried out by means of the Wilcoxon signs test. To
estimate the performance of these formulae a curve of
receptor operative characteristics (ROC) was obtained
with a cut off point at 160 mg/dl (mg/dl).
RESULTS
Three-hundred fifteen registers were collected. There
were 167 (53%) females and 148 (47%) males. The
average age was 54 years (±15.8) and 50.9 years (±16.3),
respectively. Table 1 shows demographics and labora-
tory values according to gender. There were no
differences regarding age, TC, LDL-Cr, and TG between
women and men, but there were differences in HDL-C.
TC, HDL-C and TG exhibited non-normal distribution
in the sample.
LDL-C levels obtained through enzymatic methods,
the Friedewald formula, and new formulae are shown in
Table 2. There was no difference between the mean of
LDL-C obtained through different methods. In relation
with relative errors shown in Table 3, it is important to
note a narrow dispersion between LDL-Cr - LDL-Cnf
(IQR=-0.112 – 0.092) and LDL-Cf-LDL-Cnf (IQR=-
0.098 - 0.095). The two relative errors were lower than
the 0.012 recommended by the WGLM. There were no
statistical differences between the relative errors.
Figure 1 shows a scatter plot of estimated LDL-Cnf
against global LDL-Cr global discriminated by sex.
Additionally, Table 4 shows these discriminated
intraclass correlation coefficients by sex and triglyceride
levels greater than or equal to 400 mg/dl and under 400
mg/dl. Both LDL-Cf and LDL-Cnf showed regular
correlation at TG levels equal to or greater than 400 mg/
dl. Moreover, there was no significant number of
observations in this range. The intraclass correlation
coefficient between LDL-Cr and LDL-Nf was 0.917
(95% CI: 0.896-0.933; F: 11.98, p<0.001) and between
LDL-Cr and LDL-Cf it was 0.929 (95% CI: 0.912-
0.943; F: 14.10, p<0.001).
Statistical differences among different correlation
coefficients were established by dependent correlations
using the formula developed by Hotelling and Glass-
Stanley. This test did not show statistical differences
between r(rLDL-fLDL) and r(rLDL-nfLDL); (t=0.637
F: 0.318 p=0.728).
Figure 2 shows an ROC curve between LDL-Cf and
LDL-Cnf at the cut off point of 160 mg/dl using LDL-
Cr as the gold standard. In this graph there is no
difference in the areas under the ROC curve in the two
methods described initially.
DISCUSSION
Cardiovascular disease constitutes an important
burden for public health today, suggesting a transition
in the epidemiological profile in these countries.
 In a recent study, the World Health Organization
(WHO) estimates that cardiovascular disease is the
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leading cause of death in the world, particularly among
women; such disease caused almost 32% of all deaths
in women and 27% in men in 20048. This scenario calls
for improving the approach and characterization of
cardiovascular risk in the patients.
Although there is consensus about the importance of
the accurate determination of LDL-C levels through
enzymatic methods, especially in most patients with
high cardiovascular risk, there are many barriers and
limitations in developing countries to access this
technology, particularly in low socioeconomic sectors.
Development of alternatives and cheaper formulae can
Table 1
Characteristic patient demographic and laboratory values











































































































1. Test for comparison between groups (sex) (chi2 or Fisher, depending on data).
2. Mean and standard deviation (SD) or median and interquartile range (IQR), depending on normality or not in the distribution at total
variable.
3. ATP III classification of total, LDL, and HDL cholesterol and triglycerides.
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Table 4
Global Intraclass Correlation Coefficient by sex and triglyceride levels
                       LDL-Cr vs.       95% IC      p     LDL-Cr vs.   95% IC  p     LDL-Cnf vs.  95% IC      p
                                       LDL-Cnf                                       LDL-Cf                                        LDL-Cf
Global n=315 0.92 0.90-0.93 0.001 0.93 0.91-0.94 0.001 0.95 0.94-0.96 0.001
Men n=148 0.94 0.92-0.96 0.001 0.95 0.93-0.96 0.001 0.98 0.97-0.98 0.001
Women n=167 0.90 0.87-0.93 0.001 0.92 0.89-0.94 0.001 0.96 0.95-0.97 0.001
TG >400 n= 23 0.78 0.48-0.91 0.001 0.81 0.54-0.91 0.001 0.99 0.96-0.99 0.001
TG <400 n=292 0.93 0.91-0.94 0.001 0.94 0.93-0.95 0.001 0.96 0.94-0.97 0.001
Men with TG >400 n=15 0.78 0.48-0.91 0.001 0.81 0.54-0.92 0.001 0.99 0.96-0.99 0.001
Men with TG <400 n=133 0.95 0.93-0.96 0.001 0.96 0.94-0.97 0.001 0.98 0.97-0.99 0.001
Table 3
Relative errors  and  comparison of errors among methods
        Errors                               Median of errors (IQR)1       Comparison of median of errors          p
LDL-Cr and LDL-Cf 0.0054 (-0.89 – 0.079) Z = 0.520 0.60272
LDL-Cr and LDL-Cnf -0.0071 (-0.112 – 0.092) Z = -0.014 0.98912
LDL-Cf and LDL-Cnf 0.0052 (-0.098 – 0.095) Z = -0.821 0.41192
1.  Maximum relative error accepted according to WGLM: ±0.12.    2.  Wilcoxon signed-rank test (Ho: error 1 = error 2)
Table 2
LDL-C obtained by direct method, Friedewald formula, and new formulae
Method                Mean (ED)           95% IC      Mean differences       (DE)1                     p
                                                                                                       95% IC
LDL-Cr 113.48(1.82) 109.91 - 117.06 01 0
LDL-Cf 113.24(2.02) 109.26 - 117.21 0.24 (17.5)1 -1.69 – 2.19 0.80243
LDL-Cnf 112.67(2.11) 108.51 - 116.83 0.81 (19.4)1 -1.33 – 2.96 0.4573
LDL-Cf-LDL-Cnf - - 0.56 (15.1)2 -1.10 – 2.24 0.5063
1.  Mean difference and standard deviation (SD) between Friedewald formula (LDL-Cf) or new formulae (LDL-Cnf), and direct method
(LDL-Cr).
2. Mean difference between Friedewald formula and new formula.
3. Paired T test (Ho: mean LDL-Cf/nf – LDL-Cr = 0).
contribute to determining levels of this lipoprotein in
individuals with limited economic resources.
Despite the fact that this study was developed by
using the database from a reference center, it is
remarkable that there is a predominance of women,
who are the predominant sex representing 51.2% ver-
sus 48.8% in Colombia9. Regarding age, there is majority
of adults above 45 years of age (71.1%) who are the
most affected group in Colombia with dyslipidemia,
hypertension, and diabetes mellitus, requiring strict
monitoring or screening via this test10.
Considering the population of this study in a reference
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Figure 1. Scatter plot of estimated LDL-Cnf against LDL-Cr by sex.
Pearson Correlation Coefficient (r) global and by sex
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Figure 2. Receiver-Operating Characteristic curves for comparison of estimates of LDL-Cholesterol
for New Formula (NF) and Friedewald Formula (FF). The diagnosis for high and very-high
LDL-Cholesterol was made via direct method (Gold Standard)
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center, where a vast number of patients are expected to
have multiple co-morbidities, 49% of TC values are
optimal. One possibility is that these patients had been
taking medications (e.g., statins or fibrates) or
therapeutic changes in the life style have followed once
the test had been carried out and these factors helped in
reaching this goal.
 The absence of these variables (co-morbidities and
medications) represents a limitation to this study.
Regarding HDL-C, 41% of the patients had low levels
of this lipoprotein according to sex, 41.3% had normal
levels, and 17.7% had high levels. Although there are
statistically significant differences between men and
women, the proportion of low levels of HDL-C was
very similar (43.1% versus 38.5%). This result contrasts
with those obtained in the 2005 National Survey of
Demographics and Health, where 58.9% and 62.8% of
the general population in Valle del Cauca and Colom-
bia had HDL-C levels under 40 mg/dl, respectively;
likewise, there are differences in the proportion of
HDL-C values above 60 mg/dl from this study with
those populations (17.7% versus 4.9% and 4.5%,
respectively)10. These differences could be explained
by the kinds of samples utilized in each study. Also, the
proportion of patients with better values in this study in
comparison with others probably reflects non-
pharmacological and pharmacological interventions,
but this can not to be established. Thus, there is no
significant statistical difference in triglyceride levels
between men and women. Nevertheless, one limitation
of this study is the reduced number of patients with
triglyceride levels over 400 mg/dl (7.3%), which
hindered evaluating the performance of the new formulae
in this range. The most frequently observed LDL-Cr
levels were those under 130 mg/dl (71.4%) and did not
show statistically significant differences; however, there
were a reduced number of observations over 160 mg/dl
(7.9%). Nevertheless, the strength of this study is that
the distribution of the variables and selection of patients
in a reference center increase the probability of it being
a heterogeneous sample including a broad spectrum of
patients.
The contrast of hypothesis did not show differences
in relation to the mean, just as there are no differences
in the medians of the errors relative to the different
estimations. It is important to emphasize that the relative
error obtained from the new formulae was less than the
12% recommended by WGLM  but there was a wide
dispersion (-0.07% IQR: (-0.112 – 0.092)  however, the
error shown by the Friedewald formula was similar
(median: -0.07% and SD: ±17.3%). These results
contrast with those of other studies that have
demonstrated that the Friedewald formula exhibits errors
ranging from 4.7% to 63.6%, depending on triglyceride
levels11-14.
Moreover, the area under the ROC curves showed a
similar performance for the Friedewald formula and the
new formulae at cutoff values of 160 mg/dl. This cutoff
value was chosen because it represents the limit of high
levels according to ATP III.
Although the use of these new formulae could
represent an alternative and economic way to determi-
ne LDL-C levels in deprived contexts, a cost-efficiency
analysis is out of the scope of this study. Moreover, it
is necessary to establish the accuracy of these formulae
in other populations and to evaluate the performance
with triglycerides and LDL-Cr levels over 400 mg/dl
and 130 mg/dl, respectively.
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